Iomar Barrett

Iomar Barrett was diagnosed with ALS in April 2024. His current focus is bringing a novel gene therapy to those with sporadic ALS via Celosia Therapeutics. He is a retired hedge fund manager, based in Monaco. He is married with two young children.

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.

Articles by Iomar Barrett

October 1, 2025 by Iomar Barrett

Guest Voice: The ALS progression story we don’t often see

Much of what people understand about ALS progression comes from the stories they see and hear most often —…